Synthesis and evaluation of novel monosubstituted sulfonylurea derivatives as antituberculosis agents. 2012

Li Pan, and Ying Jiang, and Zhen Liu, and Xing-Hai Liu, and Zhuo Liu, and Gang Wang, and Zheng-Ming Li, and Di Wang
State-Key Laboratory of Elemento-Organic Chemistry, National Pesticide Engineering Research Center(Tianjin), Nankai University, Tianjin 300071, China.

A series of novel monosubstituted sulfonylurea derivatives 10a-y were synthesized and characterized by (1)H NMR, (13)C NMR and HRMS. These compounds were evaluated against Mycobacterium tuberculosis H37Rv in vitro. The results showed compounds 10f, 10k and 10s exhibited moderate antituberculosis activities with MIC values in the range of 20-100 mg/L. Compounds 10b and 10o displayed good antituberculosis activities (MIC 10 mg/L), which were comparable with that of the sulfometuron methyl. Both of the two compounds showed little cytotoxicities, with an IC(50) against THP-1 cells greater than 100 mg/L.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

Li Pan, and Ying Jiang, and Zhen Liu, and Xing-Hai Liu, and Zhuo Liu, and Gang Wang, and Zheng-Ming Li, and Di Wang
June 2007, European journal of medicinal chemistry,
Li Pan, and Ying Jiang, and Zhen Liu, and Xing-Hai Liu, and Zhuo Liu, and Gang Wang, and Zheng-Ming Li, and Di Wang
October 2004, Journal of medicinal chemistry,
Li Pan, and Ying Jiang, and Zhen Liu, and Xing-Hai Liu, and Zhuo Liu, and Gang Wang, and Zheng-Ming Li, and Di Wang
January 2009, Bioorganic & medicinal chemistry letters,
Li Pan, and Ying Jiang, and Zhen Liu, and Xing-Hai Liu, and Zhuo Liu, and Gang Wang, and Zheng-Ming Li, and Di Wang
April 2014, Molecules (Basel, Switzerland),
Li Pan, and Ying Jiang, and Zhen Liu, and Xing-Hai Liu, and Zhuo Liu, and Gang Wang, and Zheng-Ming Li, and Di Wang
March 2011, Journal of medicinal chemistry,
Li Pan, and Ying Jiang, and Zhen Liu, and Xing-Hai Liu, and Zhuo Liu, and Gang Wang, and Zheng-Ming Li, and Di Wang
December 2021, Bioorganic chemistry,
Li Pan, and Ying Jiang, and Zhen Liu, and Xing-Hai Liu, and Zhuo Liu, and Gang Wang, and Zheng-Ming Li, and Di Wang
April 2023, Bioorganic & medicinal chemistry letters,
Li Pan, and Ying Jiang, and Zhen Liu, and Xing-Hai Liu, and Zhuo Liu, and Gang Wang, and Zheng-Ming Li, and Di Wang
November 2008, Magnetic resonance in chemistry : MRC,
Li Pan, and Ying Jiang, and Zhen Liu, and Xing-Hai Liu, and Zhuo Liu, and Gang Wang, and Zheng-Ming Li, and Di Wang
January 2010, Journal of medicinal chemistry,
Li Pan, and Ying Jiang, and Zhen Liu, and Xing-Hai Liu, and Zhuo Liu, and Gang Wang, and Zheng-Ming Li, and Di Wang
November 2007, ChemMedChem,
Copied contents to your clipboard!